A Mectizan Expert Committee (MEC) Statement on the use of Mectizan® during the COVID-19 pandemic: The MEC reminds country partners that Mectizan is donated only
The Mectizan Donation Program is committed to working towards WHO’s NTD Road Map 2030 targets and the path towards eliminating river blindness and lymphatic
Nov. 16, 2020 — Today at the annual meeting of the Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD), the Neglected Tropical Diseases Support
The World Health Organization (WHO) announced in this week’s WHO Weekly Epidemiological Record that Malawi has been validated to have eliminated lymphatic filariasis as a public health problem.
This is the Mectizan Donation Program and Merck & Co., Inc., grant application to assist non-governmental organization (NGO) partners with resuming mass drug administration
This is footage[1] of microfilariae was captured in a 59-year-old man’s anterior chamber of the eye. The man lives in an onchocerciasis-endemic area in
A recent study informed that ivermectin was successfully used in vitro for the treatment of SARS-CoV-2 in experimentally infected cells and two preprint publications
This short film reveals the dedication of Edoa Pierre, a community drug distributor, as he works towards eliminating onchocerciasis (river blindness) in Nlongbon, Cameroon,
This research article focuses on the results of four rounds of mass drug administration (MDA) for cross-border districts of Côte d’Ivoire where lymphatic filariasis
In order to confirm that transmission recrudescence or importation does not occur for lymphatic filariasis (LF) after mass drug administration (MDA), the WHO recommends
This research article examines the Ov16 (onchocerciasis) and Wb123 (lymphatic filariasis) seroprevalence in the Bakoye and Falémé foci in Mali after 24 – 25
This short film covers the movement to eliminate Onchocerciasis (river blindness) in Cameroon, Africa. Follow our Vimeo account for more video footage from the
